This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_ANUS_ANAL_EXALLC for full statistics.
Carcinoma in situ of anus and anal canal
CD2_INSITU_ANUS_ANAL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
520053 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
33 |
4. Check minimum number of eventsNone |
33 |
5. Include endpointsNone |
33 |
6. Filter based on genotype QC (FinnGen only) |
33 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D01
- Name in latin
- Carcinoma in situ laryngis
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of anus and anal canal
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of anus and anal canal
- Carcinoma in situ of other and unspecified digestive organs
- Carcinoma in situ of other and unspecified digestive organs
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 33 | 20 | 13 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 63.32 | 61.93 | 65.45 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
18
24
15.30
14.24
1.7
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
39
7.02
7.05
2.6
2.9
e6/l
4.5
1.9
—
10
22
(4035726)
12
22
8.00
6.86
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
23
99
5.37
4.98
3.8
3.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
19
73
4.78
4.68
17.1
7.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
45
4.67
4.25
2.8
2.6
e6/l
0.6
1.1
—
8
27
(36304419) Bacteria [Presence] in Urine
19
79
4.31
4.10
3.9
2.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
21
94
4.39
4.09
4.0
3.1
e6/l
23.5
40.9
0.46
16
74
(3018095) Leukocytes [#/volume] in Urine
22
103
4.41
4.01
4.5
3.6
e6/l
132.2
65.9
0.31
16
77
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
5
14.20
3.92
1.8
1.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
19
81
4.17
3.92
4.2
2.8
e6/l
1.1
0.3
0.63
14
60
(40768804) Tissue Pathology biopsy report
22
105
4.29
3.86
5.1
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
17
6.84
3.83
3.1
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
12
39
4.26
3.51
3.4
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
19
89
3.67
3.28
3.7
2.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
10
30
4.35
3.20
1.9
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
10
33
3.91
2.80
2.6
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
20
107
3.21
2.63
17.2
10.8
e9/l
0.0
0.0
0.00
14
86
(3023368) Bacteria identified in Blood by Culture
16
75
3.20
2.63
7.9
4.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
17
85
3.06
2.48
12.7
4.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
14
65
3.00
2.29
3.4
2.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
9
33
3.36
2.13
8.0
9.5
mmol/l
103.4
104.7
—
9
33
(3011397) Hemoglobin [Presence] in Urine by Test strip
13
60
2.92
2.12
2.5
4.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
27
3.57
2.10
2.9
3.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
21
128
2.76
2.01
4.8
4.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
26
184
2.94
1.82
6.4
4.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
7
25
3.27
1.76
8.6
4.5
u/l
262.3
247.5
—
7
25
(3013707) Erythrocyte sedimentation rate by Westergren method
28
214
3.03
1.70
6.4
3.8
mm/h
15.5
11.2
0.68
28
203
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
19
117
2.47
1.69
1.9
2.0
pmol/l
98.4
96.4
—
10
51
(3000494) Fungus identified in Specimen by Culture
8
33
2.87
1.67
1.8
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
15
87
2.33
1.47
4.0
3.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
10
50
2.43
1.33
3.7
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
21
149
2.13
1.19
2.3
3.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
17
116
1.96
1.02
4.3
2.5
ug/l
124.1
93.1
0.59
17
108
(3044889) 12 lead EKG panel
24
188
2.01
1.02
4.5
3.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
11
66
2.00
0.93
1.4
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
47
1.92
0.88
3.1
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
0
24
0.00
0.83
0.0
2.5
—
4.0
—
0
17
(3000991) Gas panel - Venous blood
5
24
2.27
0.78
9.6
9.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
14
97
1.77
0.75
5.8
3.2
mmol/l
2.3
2.4
0.23
14
84
(3026493) Urate [Moles/volume] in Serum or Plasma
11
72
1.79
0.70
5.5
2.3
umol/l
390.3
341.4
0.65
11
60
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
20
0.00
0.62
0.0
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
15
187
0.64
0.53
3.4
2.7
u/l
81.8
42.6
0.74
15
177
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
18
213
0.66
0.47
7.0
4.0
pmol/l
14.3
15.0
0.82
18
191
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
31
1.72
0.45
3.0
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
31
1.72
0.45
3.0
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
24
265
0.65
0.44
5.1
4.6
mmol/l
4.6
4.5
0.10
24
243
(40768797) Stomach Pathology biopsy report
5
33
1.60
0.43
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
6
42
1.52
0.38
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
45
1.41
0.36
1.7
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
9
71
1.37
0.29
5.6
2.8
mg/l
65.9
104.7
—
9
40
(3015736) pH of Urine
12
99
1.33
0.24
3.5
4.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
11
0.00
0.22
0.0
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
11
0.00
0.22
0.0
4.8
—
3.8
—
0
11
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
2.0
—
79.9
—
0
10
(3020891) Body temperature
0
10
0.00
0.22
0.0
5.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
10
0.00
0.22
0.0
1.5
—
1.5
—
0
5
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
12
0.00
0.21
0.0
4.7
—
1.4
—
0
12
(40760892) CBC W Ordered Manual Differential panel - Blood
7
60
1.21
0.19
3.0
6.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6
75
0.76
0.18
3.7
3.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
27
252
1.39
0.18
7.1
6.0
mmol/mol
43.7
39.8
0.90
27
233
(3013512) EKG study
7
84
0.79
0.17
5.7
4.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
88
0.88
0.08
2.6
2.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
12
109
1.16
0.07
3.3
4.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
10
93
1.11
0.02
4.6
3.3
ng/l
2557.6
2003.3
—
10
79
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
1.1
—
0
9
(3044290) Cell count panel - Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
5.4
—
187.4
—
0
8
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
0.2
—
0
9
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4094501)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
59.4
—
0
5
(3002523) Influenza virus A Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.0
—
0.0
—
0
7
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
30.3
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
7
70
1.00
0.00
1.3
1.6
nmol/l
21.0
20.1
—
7
59
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_ANUS_ANAL – Carcinoma in situ of anus and anal canal
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).